Scilex Holding (SCLXW) Short-term Investments (2021 - 2026)

Scilex Holding (SCLXW) recorded quarterly Short-term Investments of $200000.0 in Q1 2026, down 96.77% quarter-over-quarter from $6.2 million in Q4 2025.

Scilex Holding (SCLXW) Short-term Investments (2021 - 2026) Analysis & Trends

Scilex Holding's Short-term Investments history runs 4 years deep, the most recent figure standing at $200000.0 for Q1 2026.

  • In Q1 2026, Short-term Investments changed N/A year-over-year to $200000.0; the TTM figure through Mar 2026 stood at $200000.0 (changed N/A YoY), while the FY2025 annual figure was $6.2 million, changed N/A from the prior year.
  • Short-term Investments was $200000.0 for Q1 2026 at Scilex Holding, down from $6.2 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $141.7 million in Q2 2022 to a low of $34961.0 in Q3 2022.
  • Historically, Short-term Investments has averaged $57.7 million across 3 years, with a median of $6.2 million in 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Scilex Holding - - 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 200,000.00
Dec 31, 2025 6.20 Mn
Sep 30, 2022 34,961.00
Jun 30, 2022 141.69 Mn
Mar 31, 2022 140.45 Mn
Dec 31, 2021 139.41 Mn